Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PHAT    crawled time : 19:00    save search
Phathom Pharmaceuticals Announces Positive Topline Results from PHALCON-EE Pivotal Phase 3 Erosive Esophagitis Trial
Published: 2021-10-18 (Crawled : 19:00) - biospace.com/
PHAT | $9.48 -3.26% -3.16% 420K twitter stocktwits trandingview |
Health Technology
 | | O: 2.92% H: 0.0% C: -18.53%
positive results topline phase 3 trial
Gainers vs Losers
59% 41%

Top 10 Gainers
ZCMD | $1.45 5.84% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M twitter stocktwits trandingview |
n/a
GDHG | $0.263 21.76% 25.34% 1.3M twitter stocktwits trandingview |

HOLO | $2.95 31.7% 22.49% 37M twitter stocktwits trandingview |

UMAC | $1.55 0.65% 16.13% 3K twitter stocktwits trandingview |

MTNB | $0.19 -1.04% 14.58% 950K twitter stocktwits trandingview |
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M twitter stocktwits trandingview |
Manufacturing
TAOP | $1.08 13.01% 11.51% 19K twitter stocktwits trandingview |
Technology Services
MGLD 4 | $1.13 5.61% 10.62% 200 twitter stocktwits trandingview |
Manufacturing
NURO | $3.65 2.24% 10.3% 3.9K twitter stocktwits trandingview |
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.